|
3b Films
|
|
|
|
The Exchange has sought clarification from 3B Films Ltd on September 11, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited.
|
|
|
Advanced Enzyme Tech
|
|
|
|
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on September 11, 2026
|
|
|
Apis India
|
|
|
|
Attached herewith letter explaining reason for delay of announcement of unaudited financial results for the quarter ended June 30, 2026. Kindly take note for the same.
|
|
|
Apollo Finvest (i)
|
|
|
|
The Exchange has sought clarification from Apollo Finvest India Ltd on September 11, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited.
|
|
|
Aristo Bio-tech
|
|
|
|
Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding 'Web-link of Annual Report for Financial Year 2025-26 to those Members who have not registered their e-mail addresses'.
|
|
|
Asian Petroproducts
|
|
|
|
Preferential Issue of shares Inter alia, at the Board Meeting to consider and approve the proposed Preferential Issue of Equity Shares:- The matter was placed before the Board for its consideration and deliberation. However, after due discussion, the Board was unable to arrive at a conclusive decision with respect to the proposed Preferential issue of Equity Shares. Accordingly, the matter has been deferred for further consideration and shall be placed before the Board at a subsequent meeting for detailed deliberation
|
|
|
Astec Lifesciences
|
|
|
|
Please find enclosed, our response to BSE e-mail dated September 10, 2026.
|
|
|
Bse
|
|
|
|
BSE Limited has informed the Exchange regarding 'SEBI approval on re-appointment of Shri Jagannath Mukkavilli, Non-Independent Director'.
|
|
|
Camex
|
|
|
|
The Exchange has sought clarification from Camex Ltd on September 11, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited.
|
|
|
Cell Point (india)
|
|
|
|
Cell Point (India) Limited has informed the Exchange regarding a press release dated September 11, 2026, titled "NEWSPAPER ADVERTISEMENT FOR 13th ANNUAL GENERAT MEETING,RECORD DATE AND E-VOTING INFORMATION -CELLPOINT-REG".
|
|
|
|
